Bionter
Bionter aims to innovate particle testing. Its first product is a particle counter that is fully automated and allows non-destructive sample testing.
Bionter has raised €2.9M across 1 funding round from 1 investor, most recently a Seed round in Apr 2022. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Zurich, Switzerlandwww.bionter.com ↗
Total raised
€2.9M
€2,861,230
Funding rounds
1
Investors
1
distinct backers
Active since
2022-04
latest 2022-04
Funding by year
EUR raised per yearBionter — funding by year — interactive chart.
Data table
| Bionter — funding by year | |
|---|---|
| 2022 | €2.9M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-28 | Seed | €2.9M | Dynamk Capital | View deal → |
Investors
1Related news
- Bionter Raises $3M in Seed Fundingfinsmes.com · 2022-04
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData